Prexasertib
Showing 1 - 17 of 17
Desmoplastic Small Round Cell Tumor, Rhabdomyosarcoma Trial in New York (Prexasertib, Irinotecan)
Active, not recruiting
- Desmoplastic Small Round Cell Tumor
- Rhabdomyosarcoma
- Prexasertib
- Irinotecan
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 3, 2022
Triple Negative Breast Cancer Trial in Dallas (Drug 1: LY3023414; Drug 2: Prexasertib)
Active, not recruiting
- Triple Negative Breast Cancer
- Drug 1: LY3023414; Drug 2: Prexasertib
-
Dallas, TexasBaylor University Medical Center
Jul 18, 2022
Advanced Cancers Trial in Boston (LY2606368)
Active, not recruiting
- Advanced Cancers
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 18, 2022
Solid Tumor Trial in Boston (Prexasertib, Olaparib)
Completed
- Solid Tumor
- Prexasertib
- Olaparib
-
Boston, MassachusettsDana Farber Cancer Institute
Sep 1, 2021
Cancer Trial in Boston (LY3300054, Prexasertib)
Completed
- Cancer
- LY3300054
- Prexasertib
-
Boston, MassachusettsDana Farber Cancer Institute
Apr 13, 2021
Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)
Active, not recruiting
- Brain Tumor
- +12 more
- Prexasertib
- +4 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 20, 2022
Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma Trial in Canton (ACR-368, Gemcitabine,
Recruiting
- Platinum-resistant Ovarian Cancer
- +2 more
- ACR-368
- +2 more
-
Mobile, Alabama
- +7 more
Jan 24, 2023
Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Laboratory Biomarker
Completed
- Childhood Solid Neoplasm
- +4 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +20 more
Apr 12, 2021
Tumor Metastasis, Colorectal Tumors, Breast Cancer Trial in United States (Prexasertib, Cisplatin, Cetuximab)
Completed
- Neoplasm Metastasis
- +2 more
- Prexasertib
- +7 more
-
Sarasota, Florida
- +4 more
Mar 30, 2020
Advanced Cancer Trial in Liverpool ([¹4C]Prexasertib, Prexasertib)
Completed
- Advanced Cancer
- [¹⁴C]Prexasertib
- Prexasertib
-
Liverpool, United KingdomFor additional information regarding investigative sites for thi
Jul 30, 2019
Acute Myeloid Leukemia, MDS Trial in Boston (Prexasertib, Mitoxantrone, Etoposide)
Terminated
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Prexasertib
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jun 10, 2019
Head and Neck Tumors Trial in France, United States (Prexasertib, Cisplatin, Cetuximab)
Completed
- Head and Neck Neoplasms
- Prexasertib
- +3 more
-
Birmingham, Alabama
- +3 more
Feb 12, 2019
Advanced Cancer, Metastatic Cancer, Colorectal Cancer Trial in Charlotte, Nashville, Köln (prexasertib, ralimetinib)
Completed
- Advanced Cancer
- +3 more
- prexasertib
- ralimetinib
-
Charlotte, North Carolina
- +2 more
Dec 12, 2018
Small Cell Lung Cancer Trial in Worldwide (Prexasertib)
Completed
- Small Cell Lung Cancer
- Prexasertib
-
Fayetteville, Arkansas
- +40 more
Mar 12, 2020
Tumor Trial in Chiba, Tokyo (Prexasertib)
Completed
- Neoplasm
- Prexasertib
-
Chiba, Japan
- +1 more
May 19, 2017
Advanced Cancer, Squamous Cell Carcinoma, Carcinoma, Squamous Cell of Head and Neck Trial in United States (Prexasertib)
Completed
- Advanced Cancer
- +5 more
- Prexasertib
-
Sarasota, Florida
- +4 more
May 9, 2016